##  [Comprehensive Regulatory Pathway for Brazilian Pharma Industry](/index%2ephp/webinars/comprehensive-regulatory-pathway-for-brazilian-pharma-industry) 

<a>Pharmaceuticals</a>



<a>Past Webinar</a>



## **Comprehensive Regulatory Pathway for Brazilian Pharma Industry**

**The webinar was successfully concluded on**

  **April 6, 2021.**

[Download Webinar](javascript:void(0))





We are delighted to see your interest in Freyr’s Webinar Series (FWS). The webinar on, “**Comprehensive Regulatory Pathway for Brazilian Pharma Industry”,** was successfully concluded on April 6, 2021. Here is an archived version for your perusal.

## What Was It All About?

In this webinar session, our Brazilian Regulatory expert, Roberta Rodrigues and Michael Lambell elaborated on:

- Overview of Brazilian Pharma Market &amp; ANVISA
- Why Brazil?
- Classification &amp; Registration Process of Pharmaceutical Products
- ANVISA as a Member of PIC/s
- Rx to OTC Switch
- Case Study
- Challenges Faced by New Applicant &amp; Freyr Expertise in Brazil

As a continuous practice, Freyr is destined to organize more webinar sessions related to Regulatory aspects of Life Sciences. We presume that you would like to be a part of all those sessions. If yes, let us have an opportunity to inform you about our next session.